Elvin Kedhi, MD, PhD is an Investigator at the Research Institute of the McGill University Health Centre (RI-MUHC) at the Glen site, where he is affiliated with the Cardiovascular Health Across the Lifespan Program. As a faculty member at McGill University's Faculty of Medicine, he contributes to both clinical practice and academic research in cardiology. Dr. Kedhi's research focuses on interventional cardiology, particularly coronary artery disease management, fractional flow reserve techniques, and clinical trials comparing different treatment approaches for cardiovascular conditions. His work often involves complex clinical scenarios including patients with diabetes, high bleeding risk, and multivessel coronary disease. He has pioneered research on thin-cap fibroatheroma identification and its clinical implications, as well as optimal dual antiplatelet therapy durations following stent implantation. His recent publications demonstrate a strong emphasis on comparing transcatheter and surgical approaches for treating patients with combined aortic valve stenosis and coronary artery disease. Dr. Kedhi frequently collaborates with international research teams across Europe and North America, contributing to large-scale multicenter clinical trials that shape current cardiovascular treatment guidelines. Active researcher in interventional cardiology clinical trials Focus on optimizing treatment strategies for complex coronary artery disease Expertise in fractional flow reserve and intravascular imaging techniques International collaborations across multiple continents Dr. Kedhi maintains an active clinical research program with numerous ongoing studies examining innovative approaches to cardiovascular disease management. His work bridges the gap between technological advances in cardiac interventions and practical clinical applications that improve patient outcomes.
